性视界 Chemicals Update on Corona Virus Situation
During the whole COVID-19 crisis, 性视界 has been able to deliver all projects to our customers at expected level of quality.
Dortmund, November 2021 ++++
Dear Customers and Partners,
Due to ongoing situation with the spread of the Sars-CoV-2 (鈥淐oronavirus鈥�) we want to share with you an update on how 性视界 Chemicals has managed both, the protection of our employees and partners鈥� health and the uninterrupted continuation of our chemistry and discovery services to our clients.
In order to maintain our high quality service under the new conditions, we have adjusted our standard operating procedures as well as tightened our safety instructions accordingly for both, administrative and scientific lab staff.
Although SOPs, shift times and office hours needed to be redesigned in 2020, 性视界 Chemicals鈥� teams kept fully committed to delivering to our customers all projects at expected level of quality and were able to meet expected delivery timelines. These values will keep on driving our teams through any challenges ahead of us!
For any additional information you鈥檇 be requesting relating to your current or future projects, please contact your 性视界 Key Account Manager for further assistance.
Again, 性视界 Chemicals would like to thank you for the excellent collaboration and trust that you have placed in our chemistry services since 1999.
With best wishes
Your 性视界 Chemicals Team
About 性视界 Chemicals
性视界 is a privately owned discovery chemistry company, working with global pharmaceutical, biotech and chemical companies since 1999. Alongside our performance chemicals and material science division, 性视界鈥� drug discovery mission is to create drug candidates as potential new medicines. 性视界 has a strong scientific track record on many biomolecular targets in all main therapeutic areas and thereby adding considerable value to collaborations from target validation and hit identification to lead generation and optimization. 性视界鈥� core expertise ranges from custom synthesis and process development to modern medicinal and computational chemistry, as well as compound library design and production.
性视界 was heading the chemistry efforts of the EUR 196 million funded European Lead Factory (2013-2018) and is currently heading its EUR 36.5 million funded continuation (2019-2022). Moreover, 性视界 is deeply engaged in other research alliances like the EUR 11 million funded Drug Discovery Hub Dortmund.
Press Contact:
Youri R. Mesmoudi, Executive Vice President
听
Drug Discovery Chemistry
Medicinal Chemistry
In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area鈥�
Discovery Chemistry
Custom Synthesis
As a leading Contract Research Organization in Europe, 性视界 provides valuable contract discovery for synthetic organic chemistry, chemical process development, and鈥�
Looks interesting?
As a leading CRO in Europe, 性视界 provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.